DNA is the raw material of modern medicine yet is the only part of drug development not accessible at the lab bench. DNA synthesis, the first step in most biological workflows including gene synthesis ...
DNA synthesis is vital to several processes in biopharmaceutical innovation, including the development of gene therapies, CRISPR gene editing, antisense oligonucleotides and RNA therapies. The need ...
External placement marks a key milestone in the development of Evonetix’s benchtop DNA synthesis technology in preparation for customer use and commercialization. EVONETIX LTD (‘Evonetix’), the ...
CAMBRIDGE, England--(BUSINESS WIRE)--EVONETIX LTD (‘Evonetix’), the company bringing semiconductor technology to DNA synthesis, today announced that DNA synthesized using its unique semiconductor chip ...
Matthew Hayes (Left) is the Chief Technology Officer and founder at Evonetix, a groundbreaking gene synthesis technology company created in 2015, where he deploys his expertise in multi-disciplinary ...
The synthetic DNA maker Twist Bioscience announced at the J.P. Morgan Health Care Conference earlier this month that it is developing enzymatic DNA synthesis technology. The revelation—by a major ...
DNA enzymatic synthesis represents an enormously valuable next step in harnessing the power of DNA replication and our ability to use it for developing cutting-edge, biotechnology solutions. DNA (or ...
There’s been this dream for decades. What if we could just print out an entire gene directly, one base at a time? —Daniel Lin-Arlow, Ansa Biotechnologies As scientists set their sights on cell and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results